Elizabeth Admirand

Elizabeth Admirand's work experience includes roles at several pharmaceutical companies. Elizabeth currently serves as the Associate Director and Head of Compound and Sample Management at Frontier Medicines since July 2022. Prior to this, they worked at Agios Pharmaceuticals as the Associate Director and Head of Compound Management from March 2021 to July 2022, and as the Senior Manager and Head of Compound Management from August 2019 to February 2021. Before joining Agios Pharmaceuticals, Elizabeth had various roles at Epizyme, including Senior Scientist and Manager of Research Operations from January 2019 to August 2019, Scientist in Compound Management from February 2018 to January 2019, Principal Research Associate in Compound Management from March 2016 to February 2018, Senior Research Associate in Compound Management from September 2014 to March 2016, and Research Associate in Compound Management from May 2012 to September 2014. Elizabeth also worked as a Chemistry Lab Technician at Proteostasis Therapeutics, Inc. from June 2011 to May 2012.

Elizabeth Admirand earned a Bachelor of Science degree in Chemistry from Emmanuel College (Boston) between the years 2006 and 2010.